Gender and age diverse researchers in a lab)

Independent Medical Education Grants

Independent Medical Education Grants

Independent Medical Education Grants are the cornerstone of supporting our patients by providing funds for the continuing medical education of healthcare professionals.

Grants are issued in support of programs that include, but are not limited to, medical seminars and symposia, grand rounds, sessions at physician specialty meetings and conventions, and programs for which continuing medical education credits are approved.

Educational Grants are funded in a manner that preserves the independence of educational programs from commercial influence and complies with applicable federal and state laws and regulations, accrediting body guidelines for medical education, relevant industry codes, and the CSL Behring US policy on Educational Grants.

Decisions made by CSL Behring with respect to Grant requests are not connected with or conditioned upon past, present, or future prescribing, referring, recommending, contracting, determination of formulary status, and/or utilization of any CSL Behring product.

Areas of Focus

Coagulation

Programs that increase understanding and medical expertise in the field of coagulation.

Programs that expand awareness of the challenges that patients with hemophilia face and the role of innovations in hemophilia treatment.

Programs that improve diagnostic awareness and therapeutic assessment of von Willebrand disease.

Acquired Bleeding

Programs that provide education in areas of acquired bleeding and coagulation including: warfarin reversal (administration/dosing, acute care surgery, ICH and neurocritical care, emergency department management of bleeding), treatment of direct oral anticoagulant (DOAC)-associated bleeding, bleeding in cardiac surgery,
trauma/pre-hospital care, GI bleeding, transfusion medicine, and health economic aspects of blood management and concentrate administration.

Basic science programs with clinical correlation to acquired bleeding/coagulation will also be considered.

Neuromuscular Disorders

Programs that discuss efficacy and safety in special populations and neuromuscular disorders, especially Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Programs that improve diagnostic accuracy and awareness of appropriate diagnostic assessment criteria.

Programs that foster knowledge of appropriate management and assessment of patient outcomes.

Programs that expand the knowledge of patient management using immunoglobulin therapy via the intravenous and subcutaneous routes, including infusion training of healthcare professionals.

Programs that close clinical practice gaps in neuromuscular disease management.         

Transplant

Programs designed to expand awareness of antibody-mediated rejection in solid organ transplantation, especially renal transplantation and therapies for prophylaxis, treatment and their associated outcomes.

Programs intended to expand awareness of the research into novel therapies and cutting-edge advances in solid organ transplantation.

Programs that increase awareness of the burden of illness, unmet needs and outcomes in prophylaxis and/or treatment for acute graft-versus-host-disease and their effects on graft-versus-malignancy.

Programs aimed to expand awareness of the research into novel therapies and cutting-edge advances in hematopoietic cell transplantation.         

Primary Immunodeficiency Disorders (PIDD)

Programs that raise awareness on disease burden and expand diagnosis, such as those focused on comorbidities among adults (e.g., chronic lung disease, autoimmune diseases).

Programs that expand the knowledge of therapeutic strategies for management of antibody deficiencies, including secondary immunodeficiencies.

Programs that improve diagnostic accuracy and awareness of appropriate assessment criteria.

Programs that foster knowledge and improve quality, delivery of care, utilization, and assessment of patient outcomes.

Programs that discuss innovations in the delivery of immunoglobulins.

Hereditary Angioedema (HAE)

Programs that enhance clinician’s knowledge of hereditary angioedema types I & II disease-state, epidemiology, diagnosis, and current/novel treatments for C1-Inhibitor deficiency.

Programs that cover the differential diagnosis of angioedema, its clinical signs and symptoms, pathophysiology and genetic basis of disease along with the various appropriate clinical triage and management strategies.

Programs that raise awareness around the HAE patient journey, real-world evidence, and quality of life aspects of their disease.

Programs pertaining to the management of HAE patients relevant to the managed care community.         

Alpha-1 Antitrypsin Deficiency (AATD)

Programs that enhance the knowledge around the AATD disease state, educate diverse groups of healthcare professional about AATD.

Programs that address the clinical or health economic burden of disease, support advancements in AATD research, and explore the effect and safety of AATD therapies.

Application Details

A complete educational grant application is to include the following:

  • An online application submitted through the portal.
  • A signed letter on the organization's letterhead requesting the Grant, including dates of the Program, any partners in execution of the Program and amount requested.
  • An agenda and/or brochure for the program.
  • Using the required CSL Behring template, complete all necessary fields including Estimated Income at the bottom of the sheet. For ease of review of Grant components, add additional sheets if request includes more than one Program Method. Include Descriptions to provide further information. Download Budget Template
  • Documentation regarding the purpose and outcome of the program.
  • Documentation of the hosting institution's accreditation as a CME provider (i.e., accreditation certificate), if applicable.
  • Documentation of the hosting institution's status as a tax exempt entity (i.e., IRS determination letter), if applicable.
  • A completed W-9 for the Grant Payee.

Application Request Process

  • Review "Areas of Focus" to identify if the grant request aligns with CSL Behring's areas of interest.
  • Review "Application Details" regularly for changes to the requirements to ensure the request meets all current program requirements.
  • To start an application click on "Apply Here".
  • Log in to your account. First time requestors must create an account.
  • Your request will be reviewed and we will notify you via email of the decision.
  • If your request is approved, you will be contacted regarding the Agreement and disbursement process.

Frequently Asked Questions (FAQs)

Q: How will I know if my request was received?
A: You will receive a Grant submission confirmation via email which will include your Request ID. Please keep this for your records. This email will also provide a link to the Grant application to continue to follow up on the request.

Q: How will I be notified of the decision on the Grant?
A: You will receive an email notification of the status of the Grant after the Committee completes the review.